Engineering, testing, and validation of microparticles and implants/devices for the controlled release of various therapeutic agents over extended periods of time (weeks to months and years); preformed and in-situ formed biodegradable implants; new methods for biodegradation and biocompatibility characterizations; not-biodegradable implants.
Poster # | First Name | Last Name | Abstract Title | Abstract |
100 | Marco | Block | Miniaturized screening and tailoring of preclinical formulations for subcutaneous extended-release | View |
146 | Pacome | Andele | Human mature omental adipocytes used as reservoir for paclitaxel delivery to ovarian tumor organoids. | View |
280 | Elena | Lagreca | Peptide nanocomplexes for mRNA delivery through microparticles-based microneedles. | View |
360 | Alessandro | Grattoni | Modulating the tumor immune microenvironment via controlled intratumoral immunotherapy delivery for local and abscopal cancer treatment | View |
395 | Magdy | Abdelquader | A novel thermal analysis-based approach for quantitative determination of THEDES in THEDES/polymer mixtures | View |
396 | Masoud | Adhami | Antibiotic-Loaded 3D-Printed Implantable Devices: A Prophylactic Measure against Post-Surgical Infections | View |
397 | Edouard | Badarau | A new generation of bola-amphiphiles as key components of sustained-release drug delivery systems | View |
398 | Saurabh | Bhorkade | Understanding the Influence of PLGA Residual Content on In Vitro performance of Risperidone Microsphere | View |
399 | Bianca | Brandl | 3D-Printing of Subcutaneous Implantable Drug Delivery Systems with Patient-Tailored Long-Term Release Profiles | View |
400 | Francesco | Cancilla | Development of hybrid hydrogel based on waterborne polyurethane and hyaluronic acid as bioresponsive platform for locoregional anticancer drugs delivery | View |
401 | Hunter | Chen | Highly tunable release of proteins from crosslinked PEG hydrogels | View |
402 | Daniela | Cruz | Effects of Drug-to-Excipient Ratio in Release Kinetics of Antiretrovirals in a Long-Acting Biodegradable Subcutaneous Implant. | View |
403 | Frederic | Dargelas | In-vivo near zero-order release kinetics of a 3-month long-acting silica biodegradable injectable depot of Cyanocobalamin | View |
406 | Mauro | Di Stefano | A biorelevant analytical toolbox to enable developability assessment of thermosensitive drug delivery systems for biologics | View |
407 | Nicola | Di Trani | Subdermal long-acting islatravir nanofluidic implant achieves viral load reduction in SHIV-infected non-human primates | View |
408 | Peter | Dijkshoorn | Determination of total API content in polymeric sustained release formulations by CHN elemental analysis. | View |
410 | Mikhail | Durymanov | Modification of mesenchymal stromal cells with silibinin-loaded PLGA nanoparticles improves their therapeutic efficacy for cutaneous wound repair | View |
411 | Agnese | Fragassi | Injectable Hyaluronic Acid Microparticles for Sustained Lubrication and Cartilage Protection in Osteoarthritis | View |
413 | Meliha | Gunes | Development Of Core-Shell Structure Electrospun Fibers from Emulsions | View |
414 | Marcus | Gutmann | Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2 | View |
415 | Sarah Anne | Howard | Effect of Drug Physiochemical Properties on Long-Acting Release for Injectable, Reversible Male Contraception | View |
416 | Michaela | Hrochová | HPMA-based polymer diblock structures for drug delivery | View |
417 | Sarika | Jadhav | Sirolimus loaded polymeric micro/nano particles coated long acting stent: Profiling in vitro release | View |
420 | Swetha | Kodamasimham | Codelivery of STING Agonist & Manganese from Injectable PLGA Implants for Enhanced Cancer Immunotherapy | View |
421 | Olga | Lem | The role of lipid oxidation pathway in reactive oxygen species-mediated cargo release from liposomes | View |
422 | Giuditta | Leone | Design of a long-acting vasodilator nanomedicine for inhalation in pulmonary arterial hypertension | View |
424 | Fang | Liu | Combination Therapies Using a New Controlled Delivery Technology BEPO® in Melanoma Treatment in Mice | View |
425 | Nileshkumar | Malavia | Formulation Insights into Long-Acting Hormonal Contraceptives for Advancing Generic Drug Development | View |
426 | Dalila | Miele | Characterization of the end phase degradation of PLGA, PLGA/PLA implants as biodegradable drug delivery systems | View |
427 | Takumi | Mitsuoka | Development of an implantable sustained-release device | View |
428 | Heejun | Park | Design of experiments (DoE) approach to optimize supercritical fluid extraction of emulsion (SFEE) process for preparation of peptide-loaded sustained-release PLGA microsphere | View |
429 | Charlotte | Peloso | Evaluation of minipig injection sites for subcutaneous administration of in situ forming depot formulations | View |
430 | Mikayla | Rahman | Melt-cast Microneedle Patches for Long-acting Contraceptive Delivery | View |
432 | Mckenzie | Roy | Investigating the impact of risperidone CQAs on the in vitro release of in situ forming implants | View |
433 | Ishmamul | Sadab | Protein nanosheets for prolonged and localized display of therapeutic proteins in tumor microenvironment. | View |
434 | Lakshmi | Sathi Devi | Viscoelastic injectable hydrogel loaded with hydrophobic and hydrophilic drugs for combinatorial cancer therapy. | View |
435 | Deborah | Shalev | Immiscible-Compatible TSPU/PLLA Polymer Films as Drug-Eluting Delivery Systems | View |
436 | Caroline | Sousa | Characterizing the antimalarial profile of decoquinate and initial development of drug nanocrystals towards increasing its biopharmaceutical properties | View |
438 | Maksim | Zhelezniakov | Polymer excipient analyses: A critical consideration in the development of generic long acting injectables | View |
439 | Rita | Vanbever | PEGylated elastase-inhibiting single-domain antibody fragment for the local treatment of inflammatory lung diseases | View |
440 | Lucia | Vizzoni | Development of Pluronic/carboxymethyl chitosan based thermosensitive gel for antigen sustained release in future immunological treatments | View |
441 | Chun | Wang | Controlled release of vaccines from a hydrophobic liquid polymer depot induces long-lasting antigen-specific humoral and cellular immune responses | View |
442 | Feihu | Wang | Prodrug hydrogel-based scaffold vaccine for cancer immunotherapy | View |
443 | Cameron | White | Formulation and Characterization of Composition-equivalent Exenatide-PLGA Microspheres prepared by Coacervation | View |
542 |
Nuran | Caz | Elevated ROS-levels as target for bioresponsive nanocarriers: how cancer can kill itself. | View |
1072 | Wildan Khairi | Muhtadi | Development of tamsulosin hydrochloride-loaded dissolving microneedles for the management of benign prostatic hyperplasia | View |
1142 |
Kara | Vine-Perrow | Turning up the heat on pancreatic cancer | View |
1216 | Alyssa | Kunkel | A Modular Microparticle Delivery System to Control Antigen Release Kinetics Aiming to Improve Vaccine Efficacy | View |